Literature DB >> 11809808

Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway.

Eek-hoon Jho1, Tong Zhang, Claire Domon, Choun-Ki Joo, Jean-Noel Freund, Frank Costantini.   

Abstract

Axin2/Conductin/Axil and its ortholog Axin are negative regulators of the Wnt signaling pathway, which promote the phosphorylation and degradation of beta-catenin. While Axin is expressed ubiquitously, Axin2 mRNA was seen in a restricted pattern during mouse embryogenesis and organogenesis. Because many sites of Axin2 expression overlapped with those of several Wnt genes, we tested whether Axin2 was induced by Wnt signaling. Endogenous Axin2 mRNA and protein expression could be rapidly induced by activation of the Wnt pathway, and Axin2 reporter constructs, containing a 5.6-kb DNA fragment including the promoter and first intron, were also induced. This genomic region contains eight Tcf/LEF consensus binding sites, five of which are located within longer, highly conserved noncoding sequences. The mutation or deletion of these Tcf/LEF sites greatly diminished induction by beta-catenin, and mutation of the Tcf/LEF site T2 abolished protein binding in an electrophoretic mobility shift assay. These results strongly suggest that Axin2 is a direct target of the Wnt pathway, mediated through Tcf/LEF factors. The 5.6-kb genomic sequence was sufficient to direct the tissue-specific expression of d2EGFP in transgenic embryos, consistent with a role for the Tcf/LEF sites and surrounding conserved sequences in the in vivo expression pattern of Axin2. Our results suggest that Axin2 participates in a negative feedback loop, which could serve to limit the duration or intensity of a Wnt-initiated signal.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11809808      PMCID: PMC134648          DOI: 10.1128/MCB.22.4.1172-1183.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  50 in total

1.  Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1.

Authors:  J Roose; G Huls; M van Beest; P Moerer; K van der Horn; R Goldschmeding; T Logtenberg; H Clevers
Journal:  Science       Date:  1999-09-17       Impact factor: 47.728

Review 2.  Linking colorectal cancer to Wnt signaling.

Authors:  M Bienz; H Clevers
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

3.  Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling.

Authors:  W Liu; X Dong; M Mai; R S Seelan; K Taniguchi; K K Krishnadath; K C Halling; J M Cunningham; L A Boardman; C Qian; E Christensen; S S Schmidt; P C Roche; D I Smith; S N Thibodeau
Journal:  Nat Genet       Date:  2000-10       Impact factor: 38.330

4.  Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta.

Authors:  M J Hart; R de los Santos; I N Albert; B Rubinfeld; P Polakis
Journal:  Curr Biol       Date:  1998-05-07       Impact factor: 10.834

5.  Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4.

Authors:  K Stark; S Vainio; G Vassileva; A P McMahon
Journal:  Nature       Date:  1994-12-15       Impact factor: 49.962

6.  Requirement for Wnt3 in vertebrate axis formation.

Authors:  P Liu; M Wakamiya; M J Shea; U Albrecht; R R Behringer; A Bradley
Journal:  Nat Genet       Date:  1999-08       Impact factor: 38.330

7.  Wnt/beta-catenin signaling induces the expression and activity of betaTrCP ubiquitin ligase receptor.

Authors:  V S Spiegelman; T J Slaga; M Pagano; T Minamoto; Z Ronai; S Y Fuchs
Journal:  Mol Cell       Date:  2000-05       Impact factor: 17.970

8.  Identification of a domain of Axin that binds to the serine/threonine protein phosphatase 2A and a self-binding domain.

Authors:  W Hsu; L Zeng; F Costantini
Journal:  J Biol Chem       Date:  1999-02-05       Impact factor: 5.157

9.  Domains of axin involved in protein-protein interactions, Wnt pathway inhibition, and intracellular localization.

Authors:  F Fagotto; E h Jho; L Zeng; T Kurth; T Joos; C Kaufmann; F Costantini
Journal:  J Cell Biol       Date:  1999-05-17       Impact factor: 10.539

10.  Mouse Wnt genes exhibit discrete domains of expression in the early embryonic CNS and limb buds.

Authors:  B A Parr; M J Shea; G Vassileva; A P McMahon
Journal:  Development       Date:  1993-09       Impact factor: 6.868

View more
  804 in total

1.  microRNA-dependent temporal gene expression in the ureteric bud epithelium during mammalian kidney development.

Authors:  Vidya K Nagalakshmi; Volkhard Lindner; Andy Wessels; Jing Yu
Journal:  Dev Dyn       Date:  2014-11-23       Impact factor: 3.780

2.  The E6 oncoprotein from HPV16 enhances the canonical Wnt/β-catenin pathway in skin epidermis in vivo.

Authors:  José Bonilla-Delgado; Gülay Bulut; Xuefeng Liu; Enoc M Cortés-Malagón; Richard Schlegel; Catalina Flores-Maldonado; Rubén G Contreras; Sang-Hyuk Chung; Paul F Lambert; Aykut Uren; Patricio Gariglio
Journal:  Mol Cancer Res       Date:  2011-12-07       Impact factor: 5.852

3.  ATM substrate Chk2-interacting Zn2+ finger (ASCIZ) Is a bi-functional transcriptional activator and feedback sensor in the regulation of dynein light chain (DYNLL1) expression.

Authors:  Sabine Jurado; Lindus A Conlan; Emma K Baker; Jane-Lee Ng; Nora Tenis; Nicolas C Hoch; Kimberly Gleeson; Monique Smeets; David Izon; Jörg Heierhorst
Journal:  J Biol Chem       Date:  2011-12-13       Impact factor: 5.157

4.  Mutant huntingtin-impaired degradation of beta-catenin causes neurotoxicity in Huntington's disease.

Authors:  Juliette D Godin; Ghislaine Poizat; Miriam A Hickey; Florence Maschat; Sandrine Humbert
Journal:  EMBO J       Date:  2010-06-08       Impact factor: 11.598

5.  beta-Catenin initiates tooth neogenesis in adult rodent incisors.

Authors:  F Liu; S Dangaria; T Andl; Y Zhang; A C Wright; M Damek-Poprawa; S Piccolo; A Nagy; M M Taketo; T G H Diekwisch; S O Akintoye; S E Millar
Journal:  J Dent Res       Date:  2010-06-08       Impact factor: 6.116

6.  Atlas of Wnt and R-spondin gene expression in the developing male mouse lower urogenital tract.

Authors:  Vatsal Mehta; Lisa L Abler; Kimberly P Keil; Christopher T Schmitz; Pinak S Joshi; Chad M Vezina
Journal:  Dev Dyn       Date:  2011-09-20       Impact factor: 3.780

7.  WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells.

Authors:  Yaxiong Tang; Anne R Simoneau; Wu-xiang Liao; Guo Yi; Christopher Hope; Feng Liu; Shunqiang Li; Jun Xie; Randall F Holcombe; Frances A Jurnak; Dan Mercola; Bang H Hoang; Xiaolin Zi
Journal:  Mol Cancer Ther       Date:  2009-01-27       Impact factor: 6.261

Review 8.  A Wnt survival guide: from flies to human disease.

Authors:  Andy J Chien; William H Conrad; Randall T Moon
Journal:  J Invest Dermatol       Date:  2009-01-29       Impact factor: 8.551

9.  Lrp5/β-Catenin Signaling Controls Lung Macrophage Differentiation and Inhibits Resolution of Fibrosis.

Authors:  Joseph A Sennello; Alexander V Misharin; Annette S Flozak; Sergejs Berdnikovs; Paul Cheresh; John Varga; David W Kamp; G R Scott Budinger; Cara J Gottardi; Anna P Lam
Journal:  Am J Respir Cell Mol Biol       Date:  2017-02       Impact factor: 6.914

10.  Wnt1 expression induces short-range and long-range cell recruitments that modify mammary tumor development and are not induced by a cell-autonomous beta-catenin effector.

Authors:  Young Chul Kim; Rod J Clark; Erik A Ranheim; Caroline M Alexander
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.